Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-09-03

Clinical Trial Update: Factors Affecting Aqueous Humor Outflow Facility in Patients with Uveitis

View source ↗

Summary

This clinical trial studied factors affecting aqueous humor outflow facility in patients with uveitis and glaucoma. The study has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Nebraska | Conditions: UVeitis, Glaucoma | Status: WITHDRAWN